Displaying drugs 10676 - 10700 of 12610 in total
AI-128
AI-128 is the first human demonstration of sustained release drug administration in the lung. AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the lung and how quickly they release their drug.
Investigational
Matched Description: … AI-128 is the first human demonstration of sustained release drug administration in the lung. ... AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the …
Osoresnontrine
Osoresnontrine is under investigation in clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.).
Investigational
Matched Description: … investigation in clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of ... Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia …
Serdemetan
Serdemetan has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … Serdemetan has been used in trials studying the treatment of Neoplasms. …
Ezutromid
Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Description: … Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne. …
Phloroglucinol
Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy.
Investigational
Matched Description: … Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy. …
Sepranolone
Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder.
Investigational
Matched Description: … Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder. …
Apc001
Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.
Investigational
Matched Description: … Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta. …
TBX-1400
TBX-1400 consists of human donor hematopoietic stem and progenitor cells.
Investigational
Matched Description: … TBX-1400 consists of human donor hematopoietic stem and progenitor cells. …
BCX10013
BCX10013 is a small molecule inhibitor of human complement factor D.
Investigational
Matched Description: … BCX10013 is a small molecule inhibitor of human complement factor D. …
Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells
ORBCEL-C™ is the trade name of a product composed of highly purified stromal cells derived from the human umbilical cord. The isolated cells are expanded in culture and are able to be used allogenically -- meaning that one donor’s cells can be given to other unrelated patients. These cells are...
Investigational
Matched Description: … ORBCEL-C™ is the trade name of a product composed of highly purified stromal cells derived from the human ... Enrichment of CD362 expression in MSCs is being investigated for its role in immune modulation of injured ... Regarding the modifications of these UC-MSCs, CD362, also known as syndecan-2, is a surface marker identified …
VPM4001
VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells.
Investigational
Matched Description: … VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. ... Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells. ... It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete …
Aloe vera leaf
Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern peninsula and various islands. Aloe vera, or Aloe barbadensis miller, is the most common species of Aloe that is cultivated for agricultural and medical purposes. It is a perennial succulent xerophyte with elongated...
Experimental
Matched Description: … Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern ... While aloe vera has a long history of commercial uses, it is still widely used in cosmetic, food and ... The active constituents of aloe vera include polysaccharides with protective effects on skin, as they …
Satavaptan
Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver).
Investigational
Matched Description: … Recurrence in Patients With Ascites Due to Cirrhosis of the Liver). ... Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites …
MK-1064
MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)).
Investigational
Matched Description: … and Pharmacodynamics of MK-1064 (MK-1064-001)). ... MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics …
Eltanexor
Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications).
Investigational
Matched Description: … Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications). ... Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and …
EDI-200
EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.
Investigational
Matched Description: … human receptor binding domain of ectodysplasin-A1. ... EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the …
Tegileridine
Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain).
Investigational
Matched Description: … Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain). ... Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of …
DG041
DG041 is a novel, first-in-class, orally-administered small molecule developmented for the prevention of arterial thrombosis and its complications.
DG041, an anti-platelet compound, has shown to be a selective and potent antagonist of the EP3 receptor for prostaglandins E2. EP3 is a target that associates with increased risk of various vascular...
Investigational
Matched Description: … EP3 is a target that associates with increased risk of various vascular diseases. ... DG041 is a novel, first-in-class, orally-administered small molecule developmented for the prevention of ... DG041, an anti-platelet compound, has shown to be a selective and potent antagonist of the EP3 receptor …
ILY101
ILY101 is a metal-free, non-absorbed polymeric drug designed for the selective binding and removal of phosphate anions from the gastrointestinal tract. ILY101 is being developed for the treatment of hyperphosphatemia in CKD patients on dialysis and works by reducing the systemic absorption of dietary phosphate. ILY101 is designed to allow...
Investigational
Matched Description: … by reducing the systemic absorption of dietary phosphate. ... ILY101 is a metal-free, non-absorbed polymeric drug designed for the selective binding and removal of ... ILY101 is being developed for the treatment of hyperphosphatemia in CKD patients on dialysis and works …
LCP-AtorFen
LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen is designed to be a once daily tablet offering a powerful and safe treatment of high cholesterol levels, addressing three...
Investigational
Matched Description: … atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect ... LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining ... LCP-AtorFen is designed to be a once daily tablet offering a powerful and safe treatment of high cholesterol …
Otilimab
Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).
Investigational
Matched Description: … Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA). …
Visilizumab
Visilizumab has been investigated for the treatment of Ulcerative Colitis.
Investigational
Matched Description: … Visilizumab has been investigated for the treatment of Ulcerative Colitis. …
Mavrilimumab
Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis. …
Doxifluridine
Doxifluridine has been investigated for the treatment of Stomach Cancer.
Investigational
Matched Description: … Doxifluridine has been investigated for the treatment of Stomach Cancer. …
Serlopitant
Serlopitant has been investigated for the treatment of Prurigo Nodularis.
Investigational
Matched Description: … Serlopitant has been investigated for the treatment of Prurigo Nodularis. …
Displaying drugs 10676 - 10700 of 12610 in total